Maharashtra FDA Enforces Compliance Order for Health Supplements
The Maharashtra FDA mandates strict adherence to food safety regulations for health supplements and nutraceuticals following repeated violations.
Maharashtra FDA issues a compliance order effective immediately.
1,100 licenses for health supplements are currently active in the state.
Violations include unapproved ingredients and misleading health claims.
In response to ongoing violations of food safety regulations, the Maharashtra Food and Drug Administration (FDA) has issued a statewide compliance order aimed at enforcing stricter adherence to existing norms for health supplements and nutraceuticals. This directive, dated November 20, 2026, highlights the need for compliance across the entire supply chain, including manufacturers, retailers, and e-commerce platforms.
The order comes after inspections and consumer complaints revealed significant breaches, such as the manufacture and sale of products without valid licenses, the use of unapproved ingredients, and misleading health claims. The FDA's Commissioner, Tukaram Mundhe, emphasized that these violations undermine consumer safety and trust. The compliance order mandates that all food business operators must possess valid licenses from the Food Safety and Standards Authority of India (FSSAI) and adhere to the correct product categories.
A recent coordinated search conducted on November 13 across 17 establishments in six divisions of Maharashtra resulted in the seizure of products worth over ₹1.38 crore. These products contained ingredients like Magnesium Acetyl Taurate and Nicotinamide Mononucleotide, which had not received approval from the FSSAI. The FDA's order applies to a wide range of stakeholders, including manufacturers, pharmacies, gyms, and e-commerce entities, regardless of their size or turnover.
The implications of this order are significant for the health supplement industry in Maharashtra. With 1,100 active food business licenses in this sector, the FDA's focus on compliance is expected to enhance consumer safety and ensure that products meet established health standards. The order also prohibits misleading claims regarding disease treatment and mandates that only permitted ingredients be used in products, particularly those aimed at children.
Looking ahead, the FDA will conduct risk-based inspections to ensure compliance with the new regulations. Businesses that fail to adhere to these guidelines may face penalties or revocation of their licenses. The FDA's proactive approach aims to safeguard public health while ensuring that the health supplement market operates within legal and ethical boundaries.




